Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Ligand Pharmaceuticals Inc (NASDAQ:LGND)

105.71
Delayed Data
As of Feb 17
 +0.38 / +0.36%
Today’s Change
87.11
Today|||52-Week Range
139.79
+4.04%
Year-to-Date

Stock Price Forecast

The 5 analysts offering 12-month price forecasts for Ligand Pharmaceuticals Inc have a median target of 125.00, with a high estimate of 160.00 and a low estimate of 105.00. The median estimate represents a +18.25% increase from the last price of 105.71.

Analyst Recommendations

The current consensus among 4 polled investment analysts is to Buy stock in Ligand Pharmaceuticals Inc. This rating has held steady since February, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
$1.31
Sales
$40.2M
Reporting Date
Feb 23

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 111.83%
 
 
 
 
 
 
Growthannually 0.74%
 
 
 
 
 
 

Sales

Growthquarterly 86.04%
 
 
 
 
 
 
Growthannually 54.35%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.